• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    明

    明斯特大学

    University of Muenster
    院校EST. 1631
    3,045论文总数
    12.5万引用总数

    论文量&引用量时间轴

    机构学者

    论文(3045)

    年份
    起
    –
    止
    排序
    1Coarsening Behavior of Secondary-Phase Particles in Precipitation-Hardened Alloys: a Review
    Qing-Lan Huang,Zong-De Kou, Zi-Han Wang, Shi-Yi Chen, Jun-Jie Pan, Yi-Jie Jiang, Zi-Ning Zhu,Gerhard Wilde, Xing Qiang,Tao Feng,Si Lan,Song Tang

    Precipitation-hardened alloys demonstrate significant application potential in high-end industries such as aerospace, energy storage and conversion, power generation and automotive manufacturing, owing to the exceptional stability of their microstructures and the related mechanical properties up to high temperatures. With this, these materials offer important prospects and opportunities for enhancing the sustainability of materials in critical application fields. The secondary-phase particle coarsening in precipitation-hardened alloys was reviewed, systematically revisiting the Ostwald ripening mechanism and integrating the matrix diffusion-controlled Lifshitz–Slyozov–Wagner and trans-interface diffusion-controlled models to elucidate coarsening kinetics. Recent advances in understanding how temperature, aging time, volume fraction, shape factor, plastic strain, and alloying elements regulate coarsening behavior and influence alloy properties are comprehensively analyzed. The morphological evolution of precipitates and its effect on material service performance are discussed in detail. Strategies to inhibit coarsening, including alloy composition design (e.g., introducing slow-diffusing elements and thermally stable phases), processing technology (e.g., thermomechanical treatment and nanoparticle dispersion), and external condition control, are highlighted. The precise regulation of nanoparticulate size, development of advanced heat treatment processes, and in-depth exploration of the synergistic effects between plastic strain and interfacial energy will be pivotal for optimizing microstructures and extending the service life of precipitation-hardened alloys.

    2026Journal of Iron and Steel Research International(2026)引用:92
    引用
    AI阅读
    加入学术空间
    2CT-based Lung Ventilation Metrics: Reference Ranges and Pulmonary Function Test Correlations in Healthy Individuals
    Charlotte E. van den Berg, Julian Dittrich, Sarah C. Scharm,Cornelia Schaefer-Prokop,Sabine Dettmer, Anna Hunkemoeller, Jan Eckstein, Julian Glandorf, Frank K. Wacker, Gesa H. Pöhler,Hoen-oh Shin

    CT-derived assessment of regional ventilation is possible with paired inspiration and expiration scans. Normative reference values for CT-derived ventilation remain undefined. The aim of this study is to establish reference values for pulmonary ventilation using CT, with pulmonary function tests (PFTs) as the clinical standard. In this prospective, single-center study (December 2022–April 2024), 103 healthy adults underwent spirometry-guided inspiratory and expiratory CT. Lobes were segmented automatically using TotalSegmentator. Voxel-wise ventilation was quantified as the relative air volume change between inspiration and expiration via nonlinear registration, normalized to inspiratory lung volume. CT-derived lung volumes were compared with PFT-derived total lung capacity (TLC), residual volume (RV), and vital capacity (VC). Reference intervals were reported as mean ± standard deviation and 5th–95th percentiles. Multivariable analyses assessed the effects of sex, age, height, lung region, and gravitational orientation. Ninety-one participants (mean age, 53 ± 12 years; 49 men) were included. Mean ventilation was 59.5

    2026European Radiology(2026)引用:34
    引用
    AI阅读
    加入学术空间
    3Azacitidine to Treat Measurable Residual Disease in Patients with MDS/AML: Final Long-Term Results of the RELAZA2 Trial.
    Anne Sophie Platzbecker, Julia-Annabell Georgi,Jan Moritz Middeke,Katja Sockel,Rebekka Wehner,Regina Herbst,Dominik Wolf,Claudia D Baldus, Uta Oelschlägel,Anke Mütherig,Lars Fransecky,Richard Noppeney,

    Measurable residual disease (MRD) can predict relapse in patients with advanced myelodysplastic neoplasms (MDS) or acute myeloid leukemia (AML). We report the long-term efficacy and safety of MRD-guided preemptive azacitidine treatment to prevent relapse in the phase 2 RELAZA2 trial. Patients with MDS or AML after either intensive chemotherapy only or consecutive allogeneic stem cell transplantation were prospectively screened for imminent relapse by molecular MRD assessment. Patients who became MRD positive (MRDpos) during screening received azacitidine for up to 2 years to prevent relapse. The primary endpoint was the proportion of patients alive and relapse-free six months after azacitidine start. Of 357 patients screened, 119 (33.3%) became MRDpos, of whom 95 (79.8%) were eligible for azacitidine treatment. The primary endpoint was met; 60 (63%) patients were relapse-free (95% confidence interval 54-71%, P<0.0001) six months after azacitidine initiation with no new safety signals. Of 60 patients achieving MRD response during the first six cycles of azacitidine, 31 (52%) maintained response without hematological relapse for ≥2 years following azacitidine initiation. The median treatment-free duration following azacitidine discontinuation was 20.8 months; the longest ongoing response was 104 months. After a median follow-up of 6.6 years, 15 initial responders (25%) remained alive and in remission. Among screened patients who remained continuously MRDneg, 60-month overall survival and relapse-free survival were 88% and 79%, respectively. Continuously MRDneg patients display a very favorable prognosis. A majority of MRDpos patients can be effectively treated with azacitidine with potential long-term remission even after termination of azacitidine. Clinicaltrials.gov: NCT01462578.

    2026Blood(2026)引用:3
    引用
    AI阅读
    加入学术空间
    4Comparing Fourteen Consensus Biomarkers of Aging: Epigenetic Pace of Aging As the Strongest Predictor of Mortality in BASE-II
    Valentin Max Vetter, Marit Philine Junge,Christian A. Drevon,Thomas E. Gundersen, Jan Homann,Christina M. Lill,Ulman Lindenberger,Graham Pawelec,Lars Bertram,Denis Gerstorf,Ilja Demuth

    Abstract Background In many countries, lifespan has been increasing faster than healthspan, leading to more years spent with late-life disease and highlighting the need for reliable biomarkers to measure biological aging. Methods We used data from the Berlin Aging Study II (BASE-II, 60–80 years of age at baseline, average follow-up 7.4 ± 1.5 years, range 3.9–10.4, n = 1,083) to compare 14 biomarkers of aging recently consented by an expert panel for the use as outcome measures in intervention studies: physiological (insulin-like growth factor 1 (IGF-1), growth-differentiating factor-15 (DNA methylation derived, DNAmGDF15)), inflammatory (high sensitivity C-reactive protein (CRP), interleukin-6 (IL-6)), functional (muscle mass, muscle strength, hand grip strength (HGS), Timed-Up-and-Go (TUG), gait speed, standing balance test, frailty phenotype (FP), cognitive health, blood pressure), and epigenetic (epigenetic clock, DunedinPACE). Cox proportional hazard regression analyses were performed to investigate their role in prediction of all-cause as well as cause-specific mortality. Results were adjusted for age, sex, lifestyle factors, and genetic ancestry. Results In adjusted models of all-cause mortality, HGS, IL-6, standing balance, cognitive health, and the epigenetic clock (DunedinPACE) statistically significantly predicted mortality, with the epigenetic clock (DunedinPACE) emerging as the strongest predictor. CRP, gait speed, IGF-1, blood pressure, muscle mass, DNAmGDF15, FP and TUG were not associated with mortality in this study. These results were corroborated in subgroup analyses stratified by cause of death. Feature selection identified a minimal biomarker set consisting of muscle mass, standing balance, and epigenetic clock (DunedinPACE) that predicted mortality with nearly the same discriminative accuracy (C-index = 0.63) as the full model including all biomarkers (C-index = 0.65). Conclusion Among the fourteen investigated biomarkers of aging, DunedinPACE emerged with the strongest and most consistent association with mortality.

    2026Biomarker Research(2026)引用:2
    引用
    AI阅读
    加入学术空间
    5Farewell of Jan Vom Brocke As Editor-in-Chief
    Jan vom Brocke
    2026Information Systems and e-Business Management(2026)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3045 篇论文

    合作机构(100)

    明斯特大学合作论文 94
    牛津大学合作论文 69
    慕尼黑大学合作论文 60
    乌普萨拉大学合作论文 56
    德国海德堡大学合作论文 55
    波恩大学合作论文 55
    南京大学合作论文 53
    都灵大学合作论文 51
    印第安纳大学合作论文 51
    武汉大学合作论文 50

    机构统计